Kalia SK - Search Results

1

Predicting optimal deep brain stimulation parameters for Parkinson's disease using functional MRI and machine learning.

Boutet A, Madhavan R, Elias GJB, Joel SE, Gramer R, Ranjan M, Paramanandam V, Xu D, Germann J, Loh A, Kalia SK, Hodaie M, Li B, Prasad S, Coblentz A, Munhoz RP, Ashe J, Kucharczyk W, Fasano A, Lozano AM. Boutet A, et al. Among authors: kalia sk. Nat Commun. 2021 May 24;12(1):3043. doi: 10.1038/s41467-021-23311-9. Nat Commun. 2021. PMID: 34031407 Free PMC article. Clinical Trial.

2

Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP.

Liu L, Hsu SS, Kalia SK, Lozano AM. Liu L, et al. Among authors: kalia sk. Brain Res. 2003 Dec 24;994(2):243-52. doi: 10.1016/j.brainres.2003.09.066. Brain Res. 2003. PMID: 14642650

3

To serve and protect? Interventions in the subthalamic nucleus for Parkinson's disease. Commentary on "Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease".

Kalia SK, Nash JE, Lozano AM. Kalia SK, et al. Exp Neurol. 2004 Feb;185(2):201-3. doi: 10.1016/j.expneurol.2003.10.005. Exp Neurol. 2004. PMID: 14736500 Review. No abstract available.

4

BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.

Kalia SK, Lee S, Smith PD, Liu L, Crocker SJ, Thorarinsdottir TE, Glover JR, Fon EA, Park DS, Lozano AM. Kalia SK, et al. Neuron. 2004 Dec 16;44(6):931-45. doi: 10.1016/j.neuron.2004.11.026. Neuron. 2004. PMID: 15603737 Free article.

5

New movement in Parkinson's.

Lozano AM, Kalia SK. Lozano AM, et al. Among authors: kalia sk. Sci Am. 2005 Jul;293(1):68-75. doi: 10.1038/scientificamerican0705-68. Sci Am. 2005. PMID: 16008304 No abstract available.

6

Ubiquitinylation of α-synuclein by carboxyl terminus Hsp70-interacting protein (CHIP) is regulated by Bcl-2-associated athanogene 5 (BAG5).

Kalia LV, Kalia SK, Chau H, Lozano AM, Hyman BT, McLean PJ. Kalia LV, et al. Among authors: kalia sk. PLoS One. 2011 Feb 16;6(2):e14695. doi: 10.1371/journal.pone.0014695. PLoS One. 2011. PMID: 21358815 Free PMC article.

7

α-Synuclein oligomers and clinical implications for Parkinson disease.

Kalia LV, Kalia SK, McLean PJ, Lozano AM, Lang AE. Kalia LV, et al. Among authors: kalia sk. Ann Neurol. 2013 Feb;73(2):155-69. doi: 10.1002/ana.23746. Epub 2012 Dec 7. Ann Neurol. 2013. PMID: 23225525 Free PMC article. Review.

8

Bilateral pallidal stimulation for Wilson's disease.

Sidiropoulos C, Hutchison W, Mestre T, Moro E, Prescott IA, Mizrachi AV, Fallis M, Rughani AI, Kalia SK, Lozano A, Fox S. Sidiropoulos C, et al. Among authors: kalia sk. Mov Disord. 2013 Aug;28(9):1292-5. doi: 10.1002/mds.25446. Epub 2013 Apr 3. Mov Disord. 2013. PMID: 23554137

9

Parkinson disease: Neurostimulation in PD--benefit of early surgery revealed.

Kalia SK, Lozano AM. Kalia SK, et al. Nat Rev Neurol. 2013 May;9(5):244-5. doi: 10.1038/nrneurol.2013.66. Epub 2013 Apr 16. Nat Rev Neurol. 2013. PMID: 23588359 No abstract available.

10

Deep brain stimulation for Parkinson's disease and other movement disorders.

Kalia SK, Sankar T, Lozano AM. Kalia SK, et al. Curr Opin Neurol. 2013 Aug;26(4):374-80. doi: 10.1097/WCO.0b013e3283632d08. Curr Opin Neurol. 2013. PMID: 23817213 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

181 results

Search Page